Journal profile · ONCOLOGY
Middle East Journal of Cancer
ISSN 2008-6709 · eISSN 2008-6687 · Shiraz University of Medical Sciences · Iran, Islamic Republic of
Middle East Journal of Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC charged, amount not published; review about 12 weeks (community reports); 35 articles a year; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Middle East Journal of Cancer is published by Shiraz University of Medical Sciences and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, HER2/EGFR in Cancer Research and Health Systems, Economic Evaluations, Quality of Life, together about 20.7% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine6.9%
- HER2/EGFR in Cancer ResearchMedicine6.9%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance6.9%
- Tumors and Oncological CasesMedicine6.9%
- Influenza Virus Research StudiesMedicine3.5%
- Cancer survivorship and careMedicine3.5%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology3.5%
- Lymphoma Diagnosis and TreatmentMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.9LetPub ·
- SJR 2026-06
- 0.19LetPub ·
- SNIP 2026-06
- 0.23LetPub ·
- h-index
- 4OpenAlex ·
- i10-index
- 2OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 35LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 14 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | IRR 9,000,000 | No | CC BY | |
| OpenAlex | IRR 9,000,000 | — | — | |
| LetPub | IRR 9,000,000 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Shiraz University of Medical Sciences
- Country or region
- Iran, Islamic Republic of
- Language
- English
- ISSN
- 2008-6709
- Electronic ISSN
- 2008-6687
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Middle East Journal of Cancer
What CAS zone is Middle East Journal of Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Middle East Journal of Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Middle East Journal of Cancer?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Middle East Journal of Cancer?
According to LetPub and DOAJ records, Middle East Journal of Cancer is indexed in ESCI, Scopus and DOAJ.
Is Middle East Journal of Cancer open access, and what is the APC?
Middle East Journal of Cancer is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .